Home > Insider Trading > Filing (0001179110-14-001229)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1436304	Kythera Biopharmaceuticals Inc	KYTH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559583	W John Smither	C/O Kythera Biopharmaceuticals, Inc. 27200 West Agoura Road, Suite 200 Calabasas CA 91301	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-01-21	1,125	$5.90	11,325	No	4	M	Direct
Common Stock	Disposition	2014-01-21	1,125	$42.54	10,200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-01-21	1,125	$0.00	1,125	$5.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,147		2020-10-14	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires January 19, 2015.
25% of the shares subject to the option vested on the first anniversary measured from October 1, 2010 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $42.48 to $42.63, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.